MedTrace Logo

Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)

NCT00866957 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2023-11-18

No results posted yet for this study

Summary

The purpose of the study is to compare levels of HIF-1 α (Hypoxia Inducing Factor 1-alpha) in patients who have been treated with various types of liver cancer treatments.

Conditions

Interventions

PROCEDURE

Blood draw

A two-time blood draw: one prior to cancer treatment, the second after cancer treatment. Total amount of blood approximately 8 teaspoons (40mL).

Sponsors & Collaborators

Principal Investigators

  • Laura Kulik, MD · Northwestern University, Northwestern Memorial Hospital, Northwestern Medical Faculty Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2019-07-31
Completion
2019-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00866957 on ClinicalTrials.gov